Screener
Charles River Laboratories CRL Unbilled Revenue
Unbilled Revenue at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetGrossCurrent.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Assets from contracts with customers | ||
| Client receivables | $524,810 | $518,728 |
| Unbilled revenue | 195,660 | 200,591 |
| Total | 720,470 | 719,319 |
| Less: Allowance for credit losses | (8,715) | (10,463) |
| Trade receivables and contract assets, net | $711,755 | $708,856 |
| Liabilities from contracts with customers | ||
| Current deferred revenue | $203,035 | $210,418 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's unbilled revenue?
- Charles River Laboratories (CRL) reported unbilled revenue of $195.66M in Q2 2026.
- How has Charles River Laboratories's unbilled revenue changed year-over-year?
- Charles River Laboratories's unbilled revenue decreased by 9.1% year-over-year, from $215.23M to $195.66M.
- What is the long-term trend for Charles River Laboratories's unbilled revenue?
- Over 5 years (2020 to 2025), Charles River Laboratories's unbilled revenue has grown at a 8.2% compound annual growth rate (CAGR), from $135.4M to $200.59M.
- What does unbilled revenue mean?
- Revenue that has been earned but not yet billed to customers.
Ask your AI about Charles River Laboratories's unbilled revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude